Dual PI3K/mTOR Inhibitor NVP-BEZ235 Leads to a Synergistic Enhancement of Cisplatin and Radiation in Both HPV-Negative and -Positive HNSCC Cell Lines.

Cancers (Basel) · 2022 · PMC9265133 · PMID 35804930

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an overall trendno p-value reported

However, when the data was analyzed together with data from other reports using a similar protocol [ 53 , 54 ], an overall trend of a higher cisplatin sensitivity was found for HPV pos. cells.

also in 4,871 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.